ACTEMRA sol inj 162 mg/0.9 ml ser pré 4 pce

7680631660014 CH-63166 L04AC07 07.15.0.

Active substances:

ACTEMRA sol inj 162 mg/0.9 ml ser pré 4 pce
ACTEMRA sol inj 162 mg/0.9 ml ser pré 4 pce
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6316601
CPT
-
Packaging group
4
Unit
Fertigspritze(n)
Composition
tocilizumabum 162 mg, polysorbatum 80, arginini hydrochloridum, methioninum, histidinum, histidini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml.

Articles (1)

Actemra 162 mg/0.9 ml, Injektionslösung zur subkutanen Anwendung
Injektionslösung zur subkutanen Anwendung
4
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
tocilizumabum
162.0 MG Substance Wirkstoff (Principe actif)
polysorbatum 80
- Substance HNIDK
arginini hydrochloridum
- Substance HNIDK
methioninum
- Substance HNIDK
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 1042.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2014

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
63166
Drug name
Actemra, Injektionslösung zur subkutanen Anwendung
Galenic form
LSPA
ATC Code
L04AC07
Authorization status
Z
Dispensation category
A
First authorization
12/09/2014
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, Riesenzellarteriitis, polyartikuläre juvenile idiopathische Arthritis, systemische juvenile idiopatische Arthritis

Packaging details

Description (FR)
ACTEMRA sol inj 162 mg/0.9 ml ser pré 4 pce
Description (DE)
ACTEMRA Inj Lös 162 mg/0.9 ml Fertspr 4 Stk
Market launch
12/09/2014
Narcotic (BTM)
No
Buy us a coffee Explore the data